Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling [PMID: 36548088] Laboratory literature summary: Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling
Pack your semaglutide in a travel cooler or another insulated bag, and use ice packs to keep it refrigerated
Ozempic was FDA-approved in 2017 for blood sugar control in adults with type 2 diabetes
Gaetano Morelli, Chief Medical Officer at Altasciences, noted: "As we learn more about GLP-1 RAs, we realize that they target many organ systems, including the pancreas, stomach, brain, heart, kidneys, immune system (due to reduced inflammation), skeletal muscle, and control of white and brown adipose tissue metabolism, with positive effects in fatty liver disease." Because these drugs address multiple chronic conditions simultaneously, they warrant broader clinical use